FDA.reportPublic FDA data

HYPROMELLOSE 2910 (6 MPA.S)

Substance profile for UNII 0WZ8WG20P6, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
0WZ8WG20P6
Preferred term
HYPROMELLOSE 2910 (6 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300454
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300454mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300454
FDA Substance Registration System0WZ8WG20P6precision.fda.gov/uniisearch/srs/unii/0WZ8WG20P6

DailyMed Socrata Ingredients#

Ingredient, DailyMed label, SPL version table
IngredientDailyMed labelSPL version
HYPROMELLOSE 2910 (6 MPA.S)DOCUSATE SODIUM AND SENNA2
HYPROMELLOSE 2910 (6 MPA.S)LEVETIRACETAM3
HYPROMELLOSE 2910 (6 MPA.S)CARVEDILOL - carvedilol tablet Sun Pharmaceutical Industries, Inc. These highlights do not include all the information needed to use Carvedilol Tablets safely and effectively. See full prescribing information for Carvedilol Tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 199513
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use topiramate tablets, USP safely and effectively. See full prescribing information for topiramate tablets, USPTopiramate Tablets, USP for oral use Initial U.S. Approval: 19965
HYPROMELLOSE 2910 (6 MPA.S)Metformin Hydrochloride Tablets USP Rx Only3
HYPROMELLOSE 2910 (6 MPA.S)TOPIRAMATE6
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19969
HYPROMELLOSE 2910 (6 MPA.S)ENALAPRIL MALEATE TABLETS, USP4
HYPROMELLOSE 2910 (6 MPA.S)CITALOPRAM HYDROBROMIDE3
HYPROMELLOSE 2910 (6 MPA.S)VENLAFAXINE HYDROCHLORIDE3
HYPROMELLOSE 2910 (6 MPA.S)DIVALPROEX SODIUM2
HYPROMELLOSE 2910 (6 MPA.S)ESCITALOPRAM OXALATE6
HYPROMELLOSE 2910 (6 MPA.S)LEVOFLOXACIN3
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin tablets, USP SIMVASTATIN Tablets, USP for oral use Initial U.S. Approval: 199110
HYPROMELLOSE 2910 (6 MPA.S)TRAMADOL HYDROCHLORIDE3
HYPROMELLOSE 2910 (6 MPA.S)ENALAPRIL MALEATE TABLETS, USP3
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil Hydrochloride Tablets USP, for oral use Rx Only Initial U.S. Approval: 19967
HYPROMELLOSE 2910 (6 MPA.S)Propranolol hydrochloride extended-release capsules3
HYPROMELLOSE 2910 (6 MPA.S)Metformin Hydrochloride Tablets USP Rx Only4
HYPROMELLOSE 2910 (6 MPA.S)Gemfibrozil Tablets, USP 600 mg3
HYPROMELLOSE 2910 (6 MPA.S)Citalopram Tablets, USP Rx Only4
HYPROMELLOSE 2910 (6 MPA.S)Ondansetron Tablets,USP Rx only2
HYPROMELLOSE 2910 (6 MPA.S)Sertraline Tablets, USP 25 mg, 50 mg and 100 mg Rx Only27
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 19992
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use montelukast sodium safely and effectively. See full prescribing information for montelukast sodium tablets. MONTELUKAST sodium tablets, for oral use Initial U.S. Approval: 19986
HYPROMELLOSE 2910 (6 MPA.S)Losartan Potassium Tablets, USP4
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 20042
HYPROMELLOSE 2910 (6 MPA.S)Citalopram Tablets, USP 10 mg, 20 mg, and 40 mg Rx only4
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use duloxetine delayed-release capsules USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules USP. DULOXETINE delayed-release capsules USP for oral use Initial U.S. Approval: 20042
HYPROMELLOSE 2910 (6 MPA.S)Revised: August 2014 Mirtazapine Tablets, USP Rx only2
HYPROMELLOSE 2910 (6 MPA.S)Flavoxate HCl Tablets 100 mg2
HYPROMELLOSE 2910 (6 MPA.S)Imipramine Hydrochloride Tablets USP 10 mg, 25 mg and 50 mg1000
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use divalproex sodium extended-release tablets USP safely and effectively. See full prescribing information for divalproex sodium extended-release tablets USP. DIVALPROEX Sodium Extended-Release Tablets USP, for Oral Use Initial U.S. Approval: 20002
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets. LEVETIRACETAM Tablets USP, for oral use Initial U.S. Approval: 19992
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. Quetiapine Fumarate Tablets, for oral use Initial U.S. Approval: 19975
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. Quetiapine Fumarate Tablets, for oral use Initial U.S. Approval: 19972
HYPROMELLOSE 2910 (6 MPA.S)Sertraline Tablets, USP 50 mg Iss. 09/12 Rx Only3
HYPROMELLOSE 2910 (6 MPA.S)b32fcb1b-fee4-44b8-a91c-10dfdd3f84ea3
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN Tablet, Film Coated for Oral use Initial U.S. Approval: 19967
HYPROMELLOSE 2910 (6 MPA.S)Citalopram Tablets, USP Rx Only5
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. QUETIAPINE fumarate tablets for oral use Initial U.S. Approval: 19972
HYPROMELLOSE 2910 (6 MPA.S)ENALAPRIL MALEATE TABLETS, USP2
HYPROMELLOSE 2910 (6 MPA.S)Citalopram Tablets, USP5
HYPROMELLOSE 2910 (6 MPA.S)Metformin Hydrochloride Tablets USP3
HYPROMELLOSE 2910 (6 MPA.S)Mirtazapine Tablets, USP 7.5 mg, 15 mg, 30 mg, and 45 mg Rx Only2
HYPROMELLOSE 2910 (6 MPA.S)Levetiracetam Tablets Rx Only Revised: March, 20113
HYPROMELLOSE 2910 (6 MPA.S)DRUG FACTS2
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19953
HYPROMELLOSE 2910 (6 MPA.S)Aspirin NSAIDS EC Tablet 325mg- 5gr9
HYPROMELLOSE 2910 (6 MPA.S)Sertraline Hydrochloride Tablets 25 mg, 50 mg and 100 mg4
HYPROMELLOSE 2910 (6 MPA.S)Sertraline Hydrochloride Tablets 25 mg, 50 mg and 100 mg2
HYPROMELLOSE 2910 (6 MPA.S)7d8c8762-e491-4798-8866-0db6425308e82
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets for oral use Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs, levofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.1000
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19952
HYPROMELLOSE 2910 (6 MPA.S)Entacapone Tablets, USP*2
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19953
HYPROMELLOSE 2910 (6 MPA.S)Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg, 100 mg/12.5 mg and 100 mg/25 mg6
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19923
HYPROMELLOSE 2910 (6 MPA.S)Hydroxychloroquine Sulfate Tablets, USP2
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use montelukast sodium safely and effectively. See full prescribing information for montelukast sodium. MONTELUKAST SODIUM tablets and chewable tablets for oral use Initial U.S. Approval: 19982
HYPROMELLOSE 2910 (6 MPA.S)Escitalopram Tablets, USP These highlights do not include all the information needed to use Escitalopram safely and effectively. See full prescribing information for Escitalopram. Escitalopram (Escitalopram) TABLET for ORAL use. Initial U.S. Approval: 20024
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use Tramadol Hydrochloride Extended-Release safely and effectively. See full prescribing information for Tramadol Hydrochloride Extended-Release. Tramadol Hydrochloride Extended-Release (tramadol hydrochloride) Extended-Release Capsules Initial U.S. Approval: 19952
HYPROMELLOSE 2910 (6 MPA.S)Famotidine Tablets, USP 20 mg2
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use simvastatin safely and effectively. See full prescribing information for simvastatin tablets. Simvastatin Tablets, USP Initial U.S. Approval: 19916
HYPROMELLOSE 2910 (6 MPA.S)Metformin Hydrochloride Tablets USP Rx Only2
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 19933
HYPROMELLOSE 2910 (6 MPA.S)9f5a14c2-b460-402e-acb4-04402278e64b2
HYPROMELLOSE 2910 (6 MPA.S)531112e5-db64-457d-af7d-baa86f2bcec22
HYPROMELLOSE 2910 (6 MPA.S)LUNESTA ® (eszopiclone) TABLETS 1 mg, 2 mg, 3 mg3
HYPROMELLOSE 2910 (6 MPA.S)Citalopram Tablets, USP5
HYPROMELLOSE 2910 (6 MPA.S)Clarithromycin Tablets, USP3
HYPROMELLOSE 2910 (6 MPA.S)LUNESTA ® (eszopiclone) TABLETS 1 mg, 2 mg, 3 mg3
HYPROMELLOSE 2910 (6 MPA.S)BENAZEPRIL HYDROCHLORIDE TABLETS USP, 5 mg, 10 mg, 20 mg and 40 mg 5124 5125 5126 5127 Rx only3
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19954
HYPROMELLOSE 2910 (6 MPA.S)Ondansetron Tablets, USP1
Hypromellose 2910 (6 MPA.S)8a023942-01e8-4849-aa3c-1a640ffc7fd37
HYPROMELLOSE 2910 (6 MPA.S)be65d31a-87c1-4f37-a55d-7395bfe3642a2
HYPROMELLOSE 2910 (6 MPA.S)ffc422f2-a3e0-4b48-8186-a11e4088c85e2
HYPROMELLOSE 2910 (6 MPA.S)Venlafaxine hydrochloride Extended-Release Capsules2
HYPROMELLOSE 2910 (6 MPA.S)Sentralopram AM-109
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets for oral use Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs, levofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.3
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. letrozole tablets USP ,2.5 mg Initial U.S. Approval: 19973
HYPROMELLOSE 2910 (6 MPA.S)Amoxicillin Tablets, USP2
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP for Oral Use Initial U.S. Approval: 19923
HYPROMELLOSE 2910 (6 MPA.S)These highlights do not include all the information needed to use fexofenadine hydrochloride tablets safely and effectively. See full prescribing information for fexofenadine hydrochloride. Initial U.S. Approval: 19962
HYPROMELLOSE 2910 (6 CPS)Mirtazapine Tablets, USP2
HYPROMELLOSE 2910 (6 CPS)Tramadol Hydrochloride and Acetaminophen Tablets 37.5 mg/325 mg2
HYPROMELLOSE 2910 (6 MPA.S)FENOFIBRATE TABLETS, 54 mg and 160 mg2
HYPROMELLOSE 2910 (6 MPA.S)eb0cd037-1e48-42b1-92ef-4d4ede585bb86
hypromellose 2910 (6 cps)These highlights do not include all the information needed to use Ranexa safely and effectively. See full prescribing information for Ranexa. Ranexa (ranolazine) extended-release tablets Initial U.S. Approval: 20062
HYPROMELLOSE 2910 (6 MPA.S)5caff592-a90f-420d-a6ec-9b2dc914529e2
HYPROMELLOSE 2910 (6 MPA.S)Hydroxychloroquine Sulfate Tablets, USP2
HYPROMELLOSE 2910 (6 CPS)Citalopram Tablets, USP2
HYPROMELLOSE 2910 (6 CPS)These highlights do not include all the information needed to use fexofenadine hydrochloride safely and effectively. See full prescribing information for fexofenadine hydrochloride. Fexofenadine Hydrochloride Tablets. Initial U.S. Approval: 19963
HYPROMELLOSE 2910 (6 MPA.S)LUNESTA2
HYPROMELLOSE 2910 (6 MPA.S)SIMVASTATIN TABLET [MICRO LABS LIMITED]90388
HYPROMELLOSE 2910 (6 MPA.S)CITALOPRAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3973
HYPROMELLOSE 2910 (6 MPA.S)MIRTAZAPINE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3919
HYPROMELLOSE 2910 (6 MPA.S)FEXOFENADINE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3814
HYPROMELLOSE 2910 (6 MPA.S)PREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3692
HYPROMELLOSE 2910 (6 MPA.S)PREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3690
HYPROMELLOSE 2910 (6 MPA.S)HYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3325
HYPROMELLOSE 2910 (6 MPA.S)LUNESTA (ESZOPICLONE) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3279
HYPROMELLOSE 2910 (6 MPA.S)PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3263
HYPROMELLOSE 2910 (6 MPA.S)SIMVASTATIN TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3252
HYPROMELLOSE 2910 (6 MPA.S)EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3219
HYPROMELLOSE 2910 (6 MPA.S)LUNESTA (ESZOPICLONE) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3209
HYPROMELLOSE 2910 (6 MPA.S)EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3196
HYPROMELLOSE 2910 (6 MPA.S)ZOCOR (SIMVASTATIN) TABLET, FILM COATED [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC]3061
HYPROMELLOSE 2910 (6 MPA.S)DIVALPROEX SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1005
HYPROMELLOSE 2910 (6 MPA.S)TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1002
HYPROMELLOSE 2910 (6 MPA.S)LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2910 (6 MPA.S)LEVETIRACETAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2910 (6 MPA.S)NALTREXONE HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2910 (6 MPA.S)BENAZEPRIL HYDROCHLORIDE TABLET, COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (6 MPA.S)DOCUSATE SODIUM AND SENNA (DOCUSATE SODIUM AND SENNA ) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (6 MPA.S)EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (6 MPA.S)ENALAPRIL MALEATE TABLET [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (6 MPA.S)LEVOFLOXACIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (6 MPA.S)LUNESTA (ESZOPICLONE) TABLET, COATED [BRYANT RANCH PREPACK]1000

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 0WZ8WG20P6 page 1 of 1 · 16 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653CAPSULEORAL600 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653CAPSULE, DELAYED RELEASEORAL156 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653CAPSULE, DELAYED RELEASE PELLETSORAL261 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653CAPSULE, EXTENDED RELEASEORAL232 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653GRANULEORAL5455 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653GRANULE, FOR SUSPENSIONORAL42 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653POWDER, FOR SUSPENSIONORAL504 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLETORAL880 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLET, CHEWABLEORAL17 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLET, COATEDORAL12 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLET, DELAYED RELEASEORAL77 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLET, EXTENDED RELEASEORAL85 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLET, FILM COATEDORAL345 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLET, FILM COATED, EXTENDED RELEASEORAL9 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLET, ORALLY DISINTEGRATINGORAL39 mg
HYPROMELLOSE 2910 (6 MPA.S)0WZ8WG20P69004653TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL174 mg